Skip to main content
Top
Published in: Breast Cancer Research 1/2010

01-05-2010 | Poster presentation

Radiotherapy fraction size sensitivity is modulated by DNA repair systems

Authors: N Somaiah, J Yarnold, F Daley, A Pearson, K Rothkamm, T Helleday

Published in: Breast Cancer Research | Special Issue 1/2010

Login to get access

Excerpt

There is level I evidence that breast cancers are significantly more sensitive to fraction size than previously thought, so that small fractions spare the cancer as much as the dose-limiting normal tissues. In skin, sensitivity to fraction size is associated with the proliferative status of cells in the basal epidermis, which are more sensitive to fraction size during the first 3 weeks of radiotherapy (RT) than during weeks 4 and 5. This study exploits RT-induced proliferation in human epidermis as a model of human cancer to investigate changes in DNA double-strand break (DSB) repair pathways postulated to determine RT fractionation sensitivity. …
Metadata
Title
Radiotherapy fraction size sensitivity is modulated by DNA repair systems
Authors
N Somaiah
J Yarnold
F Daley
A Pearson
K Rothkamm
T Helleday
Publication date
01-05-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2549

Other articles of this Special Issue 1/2010

Breast Cancer Research 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine